Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
1.650
+0.050 (3.13%)
At close: Dec 20, 2024, 4:00 PM
1.720
+0.070 (4.24%)
After-hours: Dec 20, 2024, 5:30 PM EST
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $368.39 million as of December 20, 2024. Its market cap has decreased by -52.08% in one year.
Market Cap
368.39M
Enterprise Value
265.47M
1-Year Change
-52.08%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $368.39M, a decrease of -72.20%. That is a compound annual growth rate of -28.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 368.39M | -54.20% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 379.15M |
| ZimVie | 373.14M |
| Personalis | 371.61M |
| REGENXBIO | 367.13M |
| Delcath Systems | 357.47M |
| Jupiter Neurosciences | 357.04M |
| Prime Medicine | 355.99M |
| AngioDynamics | 348.64M |